Len Dally

Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice

The promise and challenge of therapeutic genome editing

Messenger RNA-Based Vaccines Against Infectious Diseases

The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors

mRNA vaccines — a new era in vaccinology

mRNA-based therapeutics — developing a new class of drugs

Chronic Lyme Disease: A Review

Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America

Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Identification of preexisting adaptive immunity to Cas9 proteins in humans

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

Worldwide burden of HIV in transgender women: a systematic review and meta-analysis

In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells

mRNA transcript therapy

Global epidemiology of HIV infection in men who have sex with men

Nucleoside Modified mRNA Vaccines for Infectious Diseases

Microbiota Modulation of the Gut-Lung Axis in COVID-19

Lyme borreliosis

Why and where an HIV cure is needed and how it might be achieved

Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1

Rotavirus infection

Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates

Advances in Oral Subunit Vaccine Design

Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials

Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge

Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV‐1 Vaccine Candidates

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

Detection of Immune Complexes Is Not Independent of Detection of Antibodies in Lyme Disease Patients and Does Not Confirm Active Infection with Borrelia burgdorferi